Welcure Drugs & Pharmaceuticals informs about updates
Pursuant to Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI LODR), Welcure Drugs & Pharmaceuticals has informed that the Company has successfully completed all export-sourcing assignments concluded during Q1 FY 2025-26.
The above information is a part of company’s filings submitted to BSE.
